Published in J Surg Oncol on September 01, 1986
Relative Risk of Various Head and Neck Cancers among Different Blood Groups: An Analytical Study. J Clin Diagn Res (2014) 0.84
Allele frequency of ABO blood group antigen and the risk of esophageal cancer. Biomed Res Int (2014) 0.78
Is There an Association between Keloids and Blood Groups? ISRN Dermatol (2012) 0.77
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Metastatic patterns in soft-tissue sarcomas. Arch Surg (1983) 1.66
Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55
Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol (1999) 1.54
Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol (1997) 1.46
Desmoid tumors in patients with familial adenomatous polyposis. Cancer (1994) 1.44
Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. J Perinatol (2011) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Survival in metastatic ocular melanoma. Cancer (1983) 1.37
Intravenous leiomyomatosis with cardiac extension: tumor thrombectomy through an abdominal approach. J Vasc Surg (2000) 1.35
Prognostic value of lymph node dissection in malignant melanoma. Arch Surg (1980) 1.24
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Cytogenetic profile of 109 lipomas. Cancer Res (1991) 1.18
Does more intense palliative treatment improve overall survival in metastatic breast cancer patients? Cancer (1986) 1.16
Desmoid tumors and their management. Am J Surg (1985) 1.15
Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer (1988) 1.13
Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol (1984) 1.13
Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol (1996) 1.12
Liposarcomas: prognosis and management. J Surg Oncol (1980) 1.09
Anorectal melanoma: clinical features, recurrence and patient survival. Int Surg (1981) 1.04
Pyomyositis: a differential diagnosis from sarcoma. J Surg Oncol (1985) 1.02
Richter hernia of the stomach. J Surg Oncol (1998) 1.02
The surgical treatment and outcome of soft-tissue sarcoma. Arch Surg (1981) 1.01
Distant skin and soft tissue metastases from sarcomas. J Surg Oncol (1998) 1.01
Gastrointestinal metastases from malignant melanoma. Surg Oncol (1995) 1.01
Symptomatic gastrointestinal metastases from malignant melanoma. Cancer (1981) 1.00
Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer (1988) 1.00
Treatment of unknown primary melanoma. Cancer (1991) 0.99
Management of retroperitoneal sarcomas and patient survival. Am J Surg (1985) 0.99
Partial and complete internal hemipelvectomy: complications and long-term follow-up. J Am Coll Surg (1995) 0.99
The technique of popliteal lymph node dissection. Surg Gynecol Obstet (1980) 0.98
Primary malignant tumors of the upper extremity: retrospective analysis of one hundred twenty-six cases. J Hand Surg Am (1985) 0.96
Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum (1996) 0.95
Eccrine porocarcinoma. J Surg Oncol (1994) 0.95
Variants of hemipelvectomy. Am J Surg (1983) 0.95
The effect of local recurrence on survival time in adult high-grade soft tissue sarcomas. J Clin Epidemiol (1989) 0.94
Malignant melanoma of the gallbladder: report of a case and review of the literature. Am Surg (1995) 0.93
Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol (1984) 0.92
Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol (2001) 0.92
Estrogen and progesterone receptors and tamoxifen in malignant melanoma. Cancer Treat Rep (1981) 0.91
Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer (1991) 0.90
Influence of smoking on the development of lung metastases from breast cancer. Cancer (1995) 0.90
Mesenteric fibromatosis in Gardner's syndrome. Arch Surg (1978) 0.90
Feasibility of limb salvage and survival in soft tissue sarcomas. Cancer (1986) 0.90
Subungual melanoma: an eighteen-year review. Surgery (1994) 0.90
Hilar hepatojejunostomy in resection of carcinoma of the main hepatic duct junction. Surg Gynecol Obstet (1977) 0.88
Prognostic parameters in recurrent malignant melanoma. Cancer (1983) 0.88
Malignant melanoma of the anorectal region. J Surg Oncol (1995) 0.88
Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors. Surg Oncol (1995) 0.87
Gastrocolic fistula as a complication of benign gastric ulcer. Arch Surg (1979) 0.87
Abdominal wall replacement with plastic mesh in ablative cancer surgery. Surgery (1975) 0.86
Clinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases. Eur J Surg Oncol (1989) 0.86
Tumor size/symptom duration ratio as a prognostic factor in patients with high-grade soft tissue sarcomas. Eur J Cancer Clin Oncol (1988) 0.86
Biologic behavior and treatment of intransit metastasis of melanoma. Surg Gynecol Obstet (1980) 0.86
Adrenal adenocarcinomas: histologic grading and survival. J Surg Oncol (1985) 0.86
Axillary node dissection in malignant melanoma. Surg Gynecol Obstet (1981) 0.85
Tourniquet infusion versus hyperthermic perfusion. Cancer (1982) 0.85
High-dose methotrexate as secondary chemotherapy in metastatic soft-tissue sarcomas. Cancer (1980) 0.84
Axillary compression syndrome with neurapraxia due to operative positioning. Surgery (1989) 0.84
Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I. Cancer (1985) 0.84
Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatol Surg (2000) 0.84
Band 11q13 is nonrandomly rearranged in hibernomas. Genes Chromosomes Cancer (1994) 0.84
Lymphedema after groin dissection. Am J Surg (1983) 0.84
An institutional review of sarcomas of the large and small intestine. J Am Coll Surg (1995) 0.84
Increased prostaglandin E2 and cAMP phosphodiesterase levels in Kaposi's sarcoma--a virus against host defense mechanism. Res Commun Chem Pathol Pharmacol (1992) 0.84
Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol (1994) 0.83
Internal hemipelvectomy. Surg Gynecol Obstet (1984) 0.83
Blood supply of hemipelvectomy flaps: the anterior flap hemipelvectomy. Arch Surg (2001) 0.83
Long-term survival of a female patient with primary malignant melanoma of the urethra. Eur J Surg Oncol (1998) 0.83
Malignant melanoma of the scrotum: report of 2 cases. J Urol (1994) 0.83
cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma. Cancer Treat Rep (1980) 0.83
High-dose methotrexate in malignant melanoma. Cancer Treat Rep (1979) 0.83
Interhospital differences in cancer survival. J Chronic Dis (1987) 0.83
Effect of surgical treatment on stage IV melanoma. Am J Surg (1987) 0.82
Ilioinguinal lymph node dissection. Am J Surg (1981) 0.82
Forequarter amputation with fasciocutaneous deltoid flap reconstruction for malignant tumors of the upper extremity. Ann Surg Oncol (1997) 0.82
Groin dissection in malignant melanoma. Am J Surg (1986) 0.82
The development of a technique for the morphometric analysis of invasion in cancer. J Theor Biol (1984) 0.82
Spontaneous (pathologic) rupture of spleen in malignancies. Surgery (1974) 0.82
Renal cell carcinoma metastatic to skeletal muscle mass: a case report. J Surg Oncol (1981) 0.81
Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Cancer Res (1993) 0.81
Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas. Cancer Treat Rep (1980) 0.81
Malignant mesotheliomas and chemotherapy. J Surg Oncol (1980) 0.81
Trisomy 8 as a nonrandom secondary change in myxoid liposarcoma. Cancer Genet Cytogenet (1991) 0.81
Repair after radical groin dissection. J Surg Oncol (1999) 0.80
Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer (1993) 0.80
Pseudo-tumor of the calf. Eur J Surg Oncol (1993) 0.80
Vascular reconstruction for limb salvage in soft tissue sarcomas. Surgery (1987) 0.79
Tourniquet infusion chemotherapy in extremities with malignant lesions. Surg Gynecol Obstet (1979) 0.79
Cytogenetic subtype involving chromosome 13 in lipoma. Report of three cases. Cancer Genet Cytogenet (1989) 0.79
Posterior compartment resection of the thigh for soft-tissue sarcomas. J Surg Oncol (1999) 0.79
Malignant melanoma of the female genital system. Eur J Surg Oncol (1994) 0.79
Malignant melanoma with unknown primary site. J Surg Oncol (1982) 0.78
Modes of regional chemotherapy. J Surg Res (1979) 0.78
Molecular oncogene markers and their significance in cutaneous malignant melanoma. Ann Surg Oncol (1998) 0.78
Sacral resection with preservation of continence. Surg Gynecol Obstet (1986) 0.78